U.S. Nasal Cannula Market Revenue & Forecast Analysis, 2026-2035

According to the U.S. Centers for Disease Control and Prevention (CDC), chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD) affect millions of adults in the United States and remain a leading cause of hospitalization and oxygen therapy use, driving consistent demand for nasal cannula devices as a primary low-flow oxygen delivery interface in acute care, emergency settings, and home healthcare environments.

The U.S. Nasal Cannula Market has experienced consistent expansion in the last ten years, fueled by the growing occurrence of chronic respiratory illnesses like COPD, asthma, and sleep apnea, as well as a rise in hospitalizations for acute respiratory issues. The market has gained from the increasing acceptance of long-term oxygen therapy (LTOT) and the growth of home healthcare services, where nasal cannulas are commonly utilized for low-flow oxygen administration. For instance, throughout the COVID-19 pandemic, the adoption of nasal cannulas rose notably in U.S. hospitals and emergency departments as a primary oxygen support tool for patients experiencing mild to moderate respiratory distress.

The U.S. Nasal Cannula Market is anticipated to witness robust growth throughout the forecast timeframe, driven by the expanding elderly population, escalating prevalence of respiratory conditions, and a heightened preference for non-invasive oxygen delivery methods. For instance, by 2035, the use of advanced oxygen delivery devices like humidified high-flow nasal cannulas (HFNC) is anticipated to increase notably in intensive care units and emergency departments, spurred by enhanced patient comfort, greater oxygenation effectiveness, and a decreased requirement for mechanical ventilation in respiratory treatment strategies.

U.S. Nasal Cannula Market Overview

Base Year Market Size (2025): USD 2.5 Billion

CAGR: 5.3%

Forecast Year Market Size (2035): USD 4.2 Billion

Major Players:

• Medtronic plc

• Teleflex Incorporated

• ResMed Inc.

• ICU Medical, Inc.

• Smiths Medical

U.S. Nasal Cannula Market Trends

The U.S. Nasal Cannula Market is experiencing consistent growth, fueled by the growing incidence of respiratory conditions like COPD, asthma, sleep apnea, and acute respiratory infections, alongside the rising need for non-invasive oxygen delivery methods in hospitals and homecare environments.

• A significant trend is the rising use of high-flow nasal cannula (HFNC) systems, commonly utilized in emergency departments and ICUs for individuals with respiratory failure, providing enhanced oxygenation, superior humidification, and a decreased requirement for mechanical ventilation.

• There is an increasing demand in the market for home oxygen therapy products, with nasal cannulas frequently utilized in long-term oxygen therapy (LTOT) for chronic diseases like COPD, enhancing patient mobility and decreasing hospital readmissions.

• Healthcare professionals are paying more attention to patient comfort and adherence, resulting in the creation of softer, lighter, and ergonomically crafted nasal cannulas that minimize nasal discomfort during extended oxygen therapy.

• Additionally, producers are prioritizing product innovation, enhanced flow efficiency, and compatibility with smart monitoring systems, facilitating improved clinical results and broadening usage in both acute and chronic care environments.

Collectively, the increasing respiratory disease prevalence, greater adoption of home healthcare, and ongoing improvements in oxygen delivery systems are anticipated to propel the sustained expansion of the U.S. Nasal Cannula Market.

U.S. Nasal Cannula Market Analysis

By Product Type

Low flow nasal cannulas dominate the U.S. nasal cannula market due to their widespread use in routine oxygen therapy, cost-effectiveness, and strong adoption in both hospital and homecare settings

Based on type, the U.S. Nasal Cannula Market is categorized into low flow nasal cannula and high flow nasal cannula. The low flow nasal cannula segment holds the largest market share of 61.32% in 2025.

By Material Type

Plastic nasal cannulas dominate the U.S. nasal cannula market due to their low cost, wide availability, and suitability for both hospital and homecare oxygen therapy

Based on material type, the U.S. Nasal Cannula Market is categorized into plastic and silicone. The plastic segment holds the largest market share in 2025.

By End-use

Hospitals dominate the U.S. nasal cannula market due to high patient inflow, extensive oxygen therapy usage, and strong adoption in acute respiratory care settings.

Based on end-use, the U.S. Nasal Cannula Market is categorized into hospitals, ambulatory healthcare services, long-term care centers, and others. The hospitals segment holds the largest market share in 2025.